Identification of anthranilamide derivatives as potential factor Xa inhibitors: Drug design, synthesis and biological evaluation
Junhao Xing(China Pharmaceutical University), Huibin Zhang, Lingyun Yang(State Key Laboratory of Pollution Control and Resource Reuse), Yuan Zhang(Guangzhou Medical University), Qing Li(Guangxi Medical University), Jinpei Zhou, Xinning Wang(Capital Institute of Pediatrics), Leilei Zhao(Hebei Medical University), Hui Li(Shanghai Stomatological Hospital), Muxing Zhou(China Pharmaceutical University)
Cited by 28
Related Papers
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Preparation of chitosan/poly(acrylic acid) magnetic composite microspheres and applications in the removal of copper(II) ions from aqueous solutions
|Journal of Hazardous Materials|2012|293
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
|Blood Advances|2023|236
Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
|Cell stem cell|2019|179
Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis
|Journal of Autoimmunity|2019|173